HIGHLIGHTS
- who: Michael C B David and collaborators from the the University of Surrey, UK have published the article: Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimeru2019s disease: systematic review and meta-analysis, in the Journal: (JOURNAL) of 22/Dec/2021
- what: The authors focused on prospective clinical trials of the effect of a chronic course of medication, excluding single-u00ad dose studies. The authors focus on the 19 trials of Alzheimer`s disease and MCI, as the search revealed only four eligible PD trials, one in FTD, and none in Lewy Body dementia or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.